Unsurprisingly, decreased TUBB6 expression was significantly associated with increased overall survival in five independent ovarian cancer cohorts (GSE9891, GSE30161, GSE3149, GSE13876 and GSE49997) in OSov (Figure 4A). Here, TUBB6 is linked to ovarian carcinoma.